From Applications to Experimentation: The Journey Behind the EVOLVE2CARE Open Call

Behind every successful experimentation phase lies a carefully designed selection process.

For EVOLVE2CARE, the Open Call was not simply a call for proposals. It was the foundation of a structured pathway connecting HealthTech innovators with Living Labs across Europe. The Open Call marked the transition from interest to engagement, and from ideas to implementation.

This blog builds on insights from Deliverable D2.2 – “Living Labs, Innovators and Researchers Scouting and Selection Report”, which is publicly available on Zenodo and provides a transparent overview of the scouting, evaluation, and selection process behind the EVOLVE2CARE Open Call.

Designing an Open Call with Purpose

HealthTech innovation thrives when solutions are tested where care actually happens. With this in mind, the EVOLVE2CARE Open Call focused on identifying innovators and Living Labs ready to collaborate in three critical domains of transitional care:

  • Hospital discharge management
  • Remote monitoring and home-based care
  • Ageing and chronic care support

The objective was not only to select promising technologies, but to ensure alignment between innovators’ ambitions and the real-world experimentation capacity of Living Labs.

A Structured and Transparent Process

The scouting and selection process was designed to be clear, fair, and impact-oriented.

Applications were evaluated against predefined criteria that considered:

  • Relevance to transitional care use cases
  • Technical feasibility and maturity
  • Potential for measurable impact
  • Readiness for collaboration within Living Lab environments

Beyond scoring, the process also focused on matchmaking, ensuring that selected innovators were paired with Living Labs capable of supporting meaningful experimentation.

This structured approach ensures that the experimentation phase is grounded in strategic alignment rather than opportunistic selection.

From Selection to Real-World Validation

With the Open Call phase completed, selected mini-projects have now entered Living Lab environments for real-world experimentation.

This marks a critical shift. The focus moves:

  • From proposal quality to implementation performance
  • From theoretical value to practical usability
  • From innovation potential to measurable impact

Within Living Labs, solutions are tested in real healthcare contexts, involving professionals, patients, and ecosystem actors. This enables innovators to refine their tools, identify integration challenges early, and generate evidence that goes beyond technical feasibility.

Building Evidence for Sustainable Uptake

The Open Call was the first step in a broader journey toward sustainability and scalability.

By documenting the scouting and evaluation methodology, EVOLVE2CARE reinforces its commitment to transparency and replicability. The structured selection process lays the groundwork for credible experimentation outcomes, stronger positioning of project results, and future ecosystem adoption.

Readers interested in understanding the full methodology behind the Open Call scouting and selection process can explore Deliverable D2.2 – “Living Labs, Innovators and Researchers Scouting and Selection Report”, available publicly on Zenodo.

From applications to experimentation, EVOLVE2CARE continues to build a pathway where innovation is not only selected, but validated, strengthened, and positioned for real-world healthcare transformation.

EVOLVE2CARE Open Call deadline extended to 6 November 2025

In response to the strong interest generated by the EVOLVE2CARE Open Call for HealthTech Innovators and Living Labs, the project is pleased to announce an extension of the submission deadline to 6 November 2025 (17:00 Brussels Time).

The extension offers additional time for HealthTech stakeholders, researchers, SMEs, and innovators to prepare and submit their proposals. It’s a unique opportunity to collaborate with Health and Wellbeing Living Labs across Europe and accelerate innovation in the Transitional Care sector.

Through the Open Call, (up to) ten selected innovators will receive Living Lab services valued at up to €5,000, including co-creation, user engagement, product validation, and access to data and infrastructure. This support will enable innovators to test and refine their solutions in real-world environments before market launch.

The EVOLVE2CARE project team encourages all interested parties to take advantage of this extended timeline and submit their proposals by the new deadline of 6 November 2025.

EVOLVE2CARE at the Digital Public Health Conference 2025

On July 24–25, 2025, EVOLVE2CARE was represented at the International Digital Public Health Conference (DPH25) in Madeira by Ecem Özdemir from Sploro. The conference brought together experts from across the digital and public health sectors, offering a dynamic platform for sharing insights and exploring innovative collaboration.

Ecem introduced the EVOLVE2CARE Open Call to more than 60 innovators, highlighting the opportunity for them to access Living Labs services and infrastructures across Europe. Through the Open Call, selected innovators will receive experimentation services support to test and co-develop their HealthTech solutions in real-world environments.

The presence of EVOLVE2CARE at DPH25 helped raise awareness of the project’s role in fostering inclusive, human-centric healthcare innovation. By bridging innovators with a dynamic network of Living Labs, EVOLVE2CARE contributes to building a collaborative ecosystem for the co-creation and validation of impactful solutions that address the challenges of Transitional Care; a critical area where patients move between care settings such as hospital to home, or from specialised care to long-term support.